Literature DB >> 28220174

Discovery of (S)-3'-hydroxyblebbistatin and (S)-3'-aminoblebbistatin: polar myosin II inhibitors with superior research tool properties.

Sigrid Verhasselt1, Bart I Roman1, Olivier De Wever2, Kristof Van Hecke3, Rik Van Deun3, Marc E Bracke2, Christian V Stevens1.   

Abstract

In search of myosin II inhibitors with superior research tool properties, a chemical optimization campaign of the blebbistatin scaffold was conducted in this paper. (S)-Blebbistatin is the best known small-molecule inhibitor of myosin II ATPase activity. Unfortunately, as a research tool this compound has several deficiencies: it is photolabile and (photo)toxic, has low water solubility, and its (fluorescent) precipitates interfere in (fluorescence) readouts. In view of obtaining tool compounds with improved properties, both enantiomers of a series of D-ring modified polar analogs were prepared. We identified (S)-3'-hydroxyblebbistatin (S)-2 and (S)-3'-aminoblebbistatin (S)-3 as two myosin II inhibitors with a 30-fold higher water solubility than (S)-blebbistatin. These molecules furthermore do not cause interference in (fluorescence) readouts. (S)-2 and (S)-3 thus are superior alternatives to (S)-blebbistatin as research tools to study myosin II.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28220174     DOI: 10.1039/c7ob00006e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

1.  Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics.

Authors:  Wei-Ting Ho; Jung-Shen Chang; San-Fang Chou; Wei-Lun Hwang; Po-Jen Shih; Shu-Wen Chang; Muh-Hwa Yang; Tzuu-Shuh Jou; I-Jong Wang
Journal:  J Mol Med (Berl)       Date:  2019-07-13       Impact factor: 4.599

2.  A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors.

Authors:  Laszlo Radnai; Rebecca F Stremel; James R Sellers; Gavin Rumbaugh; Courtney A Miller
Journal:  J Vis Exp       Date:  2019-08-17       Impact factor: 1.355

3.  Synthesis and Evaluation of 4-Hydroxycoumarin Imines as Inhibitors of Class II Myosins.

Authors:  Jhonnathan Brawley; Emily Etter; Dante Heredia; Amarawan Intasiri; Kyle Nennecker; Joshua Smith; Brandon M Welcome; Richard K Brizendine; Thomas W Gould; Thomas W Bell; Christine Cremo
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

4.  Recovering Actives in Multi-Antitarget and Target Design of Analogs of the Myosin II Inhibitor Blebbistatin.

Authors:  Bart I Roman; Rita C Guedes; Christian V Stevens; Alfonso T García-Sosa
Journal:  Front Chem       Date:  2018-05-24       Impact factor: 5.221

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.